April 27, 2024
Market Now
LegoChem Bio obtains patent for super bacteria treatment
[DISCLOSURE] LegoChem Bio (141080) announced on March 21 that it has been granted patent for LCB10-0200, an antibiotic for super bacteria.
It is an antibiotic that is effective for Acinetobacter and pseudomonas that have shown resistance to carbapenem, according to the company which has been developing the composition at Gum Therapeutics, a joint venture with US specialists.
By Hwang You-mee (theinvestor@heraldcorp.com)
It is an antibiotic that is effective for Acinetobacter and pseudomonas that have shown resistance to carbapenem, according to the company which has been developing the composition at Gum Therapeutics, a joint venture with US specialists.
By Hwang You-mee (theinvestor@heraldcorp.com)
